Statin Use and Risk of Vascular Events Among Cancer Patients After Radiotherapy to the Thorax, Head, and Neck
Jacinthe Boulet(Montreal Heart Institute), Negareh Mousavi(McGill University), Tarek Hijal(McGill University Health Centre), Christine Lambert(Pacific Biosciences (United States)), Lyne Nadeau(McGill University Health Centre), Edward Hulten(Walter Reed National Military Medical Center), Tomas G. Neilan(Albert Einstein College of Medicine), Alice Dragomir(McGill University), James M. Brophy(McGill University Health Centre), Carolyn Freeman(McGill University), Jessica M. Peña(Cornell University)
Cited by 87
Related Papers
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
|Journal of the American College of Cardiology|2018|1.5k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline
|Journal of Clinical Oncology|2004|709
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
|European Heart Journal|2021|589